Achaogen Inc.
| Article | Date | Source |
|---|
| Achaogen Appoints Chief Medical Officer to Chief Executive Officer | September 28, 2011 | BioSpace - Breaking News |
| Achaogen Appoints Chief Medical Officer Kenneth Hillan to Chief Executive Officer | September 28, 2011 | Biotech News - Business Wire |
| Achaogen hires Genentech veteran as chief medical officer | March 22, 2011 | Health News - BizJournals.com |
| Achaogen Appoints Kenneth J. Hillan, M.B. Ch.B., to Chief Medical Officer | March 22, 2011 | Pharma News - Business Wire |
| Achaogen to Present New Data on ACHN-490 at the 50th Annual ICAAC Meeting | September 09, 2010 | Pharma News - Business Wire |
| Achaogen Wins $64M BARDA Contract to Develop Antibiotic for Biothreats | August 31, 2010 | Inside Industry - Gen |
| Achaogen wins $64M biodefense contract | August 31, 2010 | FierceBiotech |
| Achaogen Wins up to $64M BARDA Contract to Develop Clinical-Stage Antibiotic for Biothreats | August 31, 2010 | Inside Industry - Gen |
| Achaogen Awarded Contract Worth up to $64 Million by Biomedical Advanced Research and Development Authority (BARDA) for the Development of ACHN-490 | August 31, 2010 | BioSpace - Breaking News |
| New Achaogen contract worth up to $64.5M | August 31, 2010 | Health News - BizJournals.com |
| Achaogen nabs $64.5M biothreat contract | August 30, 2010 | Health News - BizJournals.com |
| Achaogen Awarded Contract Worth up to $64 Million by BARDA for the Development of ACHN-490 | August 30, 2010 | Pharma News - Business Wire |
| Flush with cash, Achaogen continues antibiotic work | July 19, 2010 | FierceBiotech |
| Achaogen raises $56 million | April 08, 2010 | Health News - BizJournals.com |
| Antibiotic maker Achaogen raises $56M | April 07, 2010 | Health News - BizJournals.com |
| Achaogen Completes $56M Fund-Raising to Take Neoglycoside Antibiotic into Phase II | April 07, 2010 | GEN News Highlights |
| Achaogen raises $56M for antibiotic work | April 07, 2010 | FierceBiotech |
| Achaogen Completes $56 Million Series C Financing | April 07, 2010 | Pharma News - Business Wire |
